Form 8-K - Current report:
SEC Accession No. 0001654954-24-015107
Filing Date
2024-12-03
Accepted
2024-12-02 18:24:09
Documents
15
Period of Report
2024-11-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm   iXBRL 8-K 25261
  Complete submission text file 0001654954-24-015107.txt   152424

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA canna-20241129.xsd EX-101.SCH 5882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE canna-20241129_lab.xml EX-101.LAB 15213
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE canna-20241129_cal.xml EX-101.CAL 901
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE canna-20241129_pre.xml EX-101.PRE 9643
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE canna-20241129_def.xml EX-101.DEF 2102
17 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 4028
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 241520426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)